PHARMAC negotiates national contracts for some hospital medical devices and has done so since 2013.
PHARMAC has negotiated national prices with suppliers on some items that DHBs are already purchasing. National contracting has achieved savings for DHBs while maintaining product choice for clinicians.
Market share procurement
As we look to increase standardisation, some products will have ‘Hospital Supply’ status.
Unlike national contracting, DHBs will need to purchase specific brands of selected product types that PHARMAC has market share agreements for. This approach offers more competitive pricing and a quality range of products, while suppliers have an assured portion of the market.
Input from clinicians and other DHB staff
We need clinical advice so that we understand the products, how they are used, the clinical risks and product evaluation needs.
PHARMAC will always seek advice before deciding which approach to take. Your views and input are essential to achieve the full benefits of this national management approach.
We will continue to work with specialist groups and consult with DHB staff as we expand our activities.
Sign up to receive our electronic newsletter Device Advice, for updated news and links to consultations for your feedback.
Last updated: 31 May 2019